ENZON PHARMACEUTICALS, INC. Uncategorized Contracts & Agreements
24 Contracts & Agreements
- Second Amendment to the Section 382 Rights Agreement, dated as of May 16, 2024, by and between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on May 22, 2024)
- Description of Enzon Pharmaceuticals, Inc.s Registered Securities (Filed With SEC on March 20, 2024)
- Description of Enzon Pharmaceuticals, Inc.s Registered Securities (Filed With SEC on February 16, 2023)
- Independent Contractor Agreement, effective as of February 24, 2022, between Enzon Pharmaceuticals, Inc. and Richard L. Feinstein (Filed With SEC on February 25, 2022)
- Description of Enzon Pharmaceuticals, Inc.s Registered Securities (Filed With SEC on February 25, 2022)
- Description of Enzon Pharmaceuticals, Inc.s Registered Securities (Filed With SEC on February 23, 2021)
- Description of Registrants Securities (Filed With SEC on February 19, 2020)
- Letter Agreement, dated January 30, 2019, between Servier IP UK Limited and Enzon Pharmaceuticals, Inc (Filed With SEC on February 21, 2019)
- SECOND AMENDMENT TO SECTION 382 RIGHTSAGREEMENT (Filed With SEC on March 24, 2017)
- EnzonPharmaceuticals, Inc. 20Kingsbridge Road Piscataway,NJ 08854 (Filed With SEC on March 21, 2016)
- AGREEMENT (Filed With SEC on March 21, 2016)
- AMENDMENT1 INDEPENDENTCONTRACTOR AGREEMENT (Filed With SEC on March 21, 2016)
- FIRST AMENDMENT TO SECTION 382 RIGHTSAGREEMENT (Filed With SEC on March 21, 2016)
- PLAN OFLIQUIDATION AND DISSOLUTION OF enzon pharmaceuticals, inc. (Filed With SEC on February 9, 2016)
- Section382 Rights Agreement Datedas of May 1, 2014 byand between ENZONPHARMACEUTICALS, INC. and CONTINENTALSTOCK TRANSFER & TRUST COMPANY asRights Agent (Filed With SEC on May 1, 2014)
- INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on March 14, 2014)
- SEPARATIONAGREEMENT (Filed With SEC on March 14, 2014)
- SEPARATIONAGREEMENT (Filed With SEC on November 12, 2013)
- ENZON PHARMACETICALS, INC Amended and Restated 2013 Outside DirectorCompensation Plan (Filed With SEC on August 6, 2013)
- Exhibit 2.1 EXECUTION VERSION ASSETPURCHASE AGREEMENT byand between KLEEPHARMACEUTICALS, INC., DEFIANTEFARMACUTICA, S.A. and SIGMA-TAUFINANZIARIA S.P.A., (solelyfor the purpose of... (Filed With SEC on November 12, 2009)
- CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL TREATMENT REQUESTED: INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED AS FOLLOWS **REDACTED**.... (Filed With SEC on March 9, 2009)
- CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL TREATMENT REQUESTED: INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED AS FOLLOWS **REDACTED**.... (Filed With SEC on March 9, 2009)
- CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL TREATMENT REQUESTED: INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED AS FOLLOWS **REDACTED**.... (Filed With SEC on March 9, 2009)
- SECOND AMENDMENT TO THE RIGHTS AGREEMENT (Filed With SEC on January 8, 2008)
